Escalating Single Dose Study of Epsi- Gam in Healthy Normal Subjects

NCT02559258 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Allergy and Immunology

Interventions

DRUG: 0.1 mg/kg epsi-gam or placebo (6:2)
DRUG: 0.3 mg/kg epsi-gam or placebo (6:2)
DRUG: 1.0 mg/kg epsi-gam or placebo (6:2)
DRUG: 3 mg/kg epsi-gam or placebo (6:2)
DRUG: 10 mg/kg epsi-gam or placebo (6:2)

Sponsor

Tunitas Therapeutics, Inc.

Collaborators

[object Object]